Literature DB >> 32772797

Treating Ischemically Damaged Porcine Kidneys with Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells During Ex Vivo Normothermic Machine Perfusion.

Merel B F Pool1, Jaël Vos1, Marco Eijken2,3, Melissa van Pel4, Marlies E J Reinders5, Rutger J Ploeg1,6, Martin J Hoogduijn7, Bente Jespersen3, Henri G D Leuvenink1, Cyril Moers1.   

Abstract

Pretransplant normothermic machine perfusion (NMP) of donor kidneys offers the unique opportunity to perform active interventions to an isolated renal graft before transplantation. There is increasing evidence that mesenchymal stromal cells (MSCs) could have a paracrine/endocrine regenerative effect on ischemia-reperfusion injury. The purpose of this study was to determine which cytokines are secreted by MSCs during NMP of a porcine kidney. Viable porcine kidneys and autologous whole blood were obtained from a slaughterhouse. Warm ischemia time was standardized at 20 min and subsequent hypothermic machine perfusion was performed during 2-3 h. Thereafter, kidneys were machine perfused at 37°C during 7 h. After 1 h of NMP, 0, 107 cultured human adipose tissue-derived MSCs, or 107 cultured bone marrow-derived MSCs were added (n = 5 per group). In a fourth experimental group, 7-h NMP was performed with 107 adipose tissue-derived MSCs, without a kidney in the circuit. Kidneys perfused with MSCs showed lower lactate dehydrogenase and neutrophil gelatinase-associated lipocalin levels in comparison with the control group. Also, elevated levels of human hepatocyte growth factor, interleukin (IL)-6, and IL-8 were found in the perfusate of the groups perfused with MSCs compared to the control groups. This study suggests that MSCs, in contact with an injured kidney during NMP, could lead to lower levels of injury markers and induce the release of immunomodulatory cytokines.

Entities:  

Keywords:  kidney transplantation; mesenchymal stromal cells; normothermic machine perfusion; organ preservation; porcine

Year:  2020        PMID: 32772797     DOI: 10.1089/scd.2020.0024

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  9 in total

Review 1.  Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics.

Authors:  Tomohisa Matsunaga; Maximilian J Roesel; Andreas Schroeter; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

Review 2.  Recent Methods of Kidney Storage and Therapeutic Possibilities of Transplant Kidney.

Authors:  Anna Radajewska; Anna Krzywonos-Zawadzka; Iwona Bil-Lula
Journal:  Biomedicines       Date:  2022-04-28

Review 3.  Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation.

Authors:  Gabriel Orozco; Meera Gupta; Roberto Gedaly; Francesc Marti
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

Review 4.  Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation.

Authors:  Lingfei Zhao; Chenxia Hu; Fei Han; Dajin Chen; Yanhong Ma; Fanghao Cai; Jianghua Chen
Journal:  Cell Tissue Res       Date:  2021-01-13       Impact factor: 5.249

Review 5.  Ex-vivo Kidney Machine Perfusion: Therapeutic Potential.

Authors:  Ruta Zulpaite; Povilas Miknevicius; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 6.  Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation.

Authors:  Jiale Li; Qinbao Peng; Ronghua Yang; Kunsheng Li; Peng Zhu; Yufeng Zhu; Pengyu Zhou; Gábor Szabó; Shaoyi Zheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 7.  Adipose-Derived Stem/Stromal Cells in Kidney Transplantation: Status Quo and Future Perspectives.

Authors:  Gabriele Storti; Evaldo Favi; Francesca Albanesi; Bong-Sung Kim; Valerio Cervelli
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

8.  Dosing Limitation for Intra-Renal Arterial Infusion of Mesenchymal Stromal Cells.

Authors:  Anders Munk; Christina Søndergaard Duvald; Michael Pedersen; Stine Lohmann; Anna Krarup Keller; Bjarne Kuno Møller; Steffen Ringgaard; Niels Henrik Buus; Bente Jespersen; Marco Eijken
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 9.  Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs.

Authors:  Christina Bogensperger; Julia Hofmann; Franka Messner; Thomas Resch; Andras Meszaros; Benno Cardini; Annemarie Weissenbacher; Rupert Oberhuber; Jakob Troppmair; Dietmar Öfner; Stefan Schneeberger; Theresa Hautz
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.